Biochemistry · Citric Acid Cycle
The Krebs cycle, also known as the citric acid cycle or tricarboxylic acid (TCA) cycle, is a central metabolic pathway that oxidizes acetyl-CoA derived from carbohydrates, fats, and proteins into carbon dioxide and high-energy electron carriers (NADH and FADH₂). It occurs in the mitochondrial matrix and plays a pivotal role in cellular respiration, linking glycolysis to oxidative phosphorylation. The cycle also provides precursors for biosynthetic pathways, including amino acid and heme synthesis.
Beyond its role in energy production, the Krebs cycle is a hub for anabolic and catabolic processes. It generates reducing equivalents (NADH and FADH₂) that fuel the electron transport chain, driving ATP synthesis. Additionally, intermediates like α-ketoglutarate and oxaloacetate serve as substrates for gluconeogenesis, lipid synthesis, and neurotransmitter production, underscoring its multifunctional nature in metabolism.
The Krebs cycle consists of eight enzymatic steps, beginning with the condensation of acetyl-CoA (2 carbons) and oxaloacetate (4 carbons) to form citrate (6 carbons), catalyzed by citrate synthase. This is followed by isomerization of citrate to isocitrate via aconitase. The cycle proceeds through oxidative decarboxylations, substrate-level phosphorylation, and regeneration of oxaloacetate, ensuring continuous operation. Each turn of the cycle yields 3 NADH, 1 FADH₂, and 1 GTP (or ATP), while releasing 2 molecules of CO₂.
The Krebs cycle is tightly regulated to meet cellular energy demands. Key regulatory enzymes include citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase, which are allosterically inhibited by high levels of ATP, NADH, and succinyl-CoA. Conversely, ADP and calcium ions activate these enzymes, promoting flux through the cycle during energy depletion. This feedback mechanism ensures efficient coupling of substrate availability and energy production.
The primary function of the Krebs cycle is to generate high-energy electron carriers for oxidative phosphorylation. Each acetyl-CoA entering the cycle produces 3 NADH and 1 FADH₂, which donate electrons to the electron transport chain, driving proton pumping and ATP synthesis. Additionally, the cycle generates 1 GTP (equivalent to ATP) via substrate-level phosphorylation during the conversion of succinyl-CoA to succinate, catalyzed by succinyl-CoA synthetase.
Intermediates of the Krebs cycle are constantly siphoned off for biosynthetic pathways, necessitating replenishment via anaplerotic reactions. For example, pyruvate carboxylase converts pyruvate to oxaloacetate, while glutamate dehydrogenase generates α-ketoglutarate from glutamate. These reactions maintain cycle integrity and ensure continuous operation, particularly in tissues with high metabolic demands, such as the liver and brain.
Deficiencies in Krebs cycle enzymes can lead to severe metabolic disorders. For instance, mutations in fumarase or succinate dehydrogenase result in accumulation of fumarate or succinate, respectively, which are associated with hereditary leiomyomatosis, renal cell carcinoma, and encephalopathy. Additionally, thiamine deficiency impairs α-ketoglutarate dehydrogenase activity, leading to Wernicke-Korsakoff syndrome, characterized by neurological dysfunction.
The Krebs cycle is a mitochondrial pathway that oxidizes acetyl-CoA to CO₂ while generating NADH, FADH₂, and GTP. It is regulated by energy status (ATP/ADP ratio) and substrate availability, with key enzymes like citrate synthase and isocitrate dehydrogenase serving as control points. The cycle also provides biosynthetic precursors, and its intermediates are replenished via anaplerotic reactions to sustain metabolic flux.
Dysfunction in Krebs cycle enzymes can lead to metabolic diseases, such as fumarase deficiency or succinate dehydrogenase mutations, which are linked to cancer and neurological disorders. Understanding the cycle’s regulation and intermediates is critical for diagnosing and managing conditions like thiamine deficiency, where impaired α-ketoglutarate dehydrogenase activity disrupts energy metabolism in the brain.
The Krebs cycle interfaces with glycolysis, fatty acid oxidation, and amino acid metabolism, making it a central node in cellular bioenergetics. Its intermediates feed into gluconeogenesis, lipogenesis, and neurotransmitter synthesis, demonstrating its role beyond ATP production. Mastery of these connections is essential for comprehending whole-body metabolism and its dysregulation in disease.